Synthesis, characterization and anti-diabetic effect of bis[(1-R-imidazolinyl)phenolato]oxovanadium(IV) complexes
Authors:
- Ryan S. WalmsleyRWRyan S. Walmsley
- Zenixole R. TshentuZTZenixole R. Tshentu
- Manuel A. FernandesMFManuel A. Fernandes
- Carminita L. FrostCFCarminita L. Frost
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Inorganica Chimica Acta
- Vol. 363 (10) , 2215-2221
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Interaction of VO2+ ion with human serum transferrin and albuminJournal of Inorganic Biochemistry, 2009
- Biospeciation of various antidiabetic VIVO compounds in serumDalton Transactions, 2009
- The burden and costs of chronic diseases in low-income and middle-income countriesThe Lancet, 2007
- The place of sulfonylureas in the therapy for type 2 diabetes mellitusMetabolism, 2006
- Type 2 diabetes: principles of pathogenesis and therapyThe Lancet, 2005
- Global Prevalence of DiabetesDiabetes Care, 2004
- Global and societal implications of the diabetes epidemicNature, 2001
- Kinetic analysis and comparison of uptake, distribution, and excretion of48V-labeled compounds in ratsJournal of Applied Physiology, 1998
- Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic ratsDiabetologia, 1993
- Effect of Vanadate on Elevated Blood Glucose and Depressed Cardiac Performance of Diabetic RatsScience, 1985